Literature DB >> 23148145

Evidence for statin therapy in polycystic ovary syndrome.

Thozhukat Sathyapalan1, Stephen L Atkin.   

Abstract

Polycystic ovary syndrome (PCOS) is a common endocrine disorder in women of reproductive age group that is associated with increased cardiovascular risk. In addition to its lipid-lowering effects, statin therapy has shown been shown to have beneficial pleiotropic effects that may contribute to their reduction in cardiovascular morbidity and mortality. In this review, the effect of statins on PCOS is discussed with reference to the underlying potential mechanism of action.

Entities:  

Keywords:  pleiotrophic action; polycystic ovary syndrome; statins

Year:  2010        PMID: 23148145      PMCID: PMC3474609          DOI: 10.1177/2042018810367984

Source DB:  PubMed          Journal:  Ther Adv Endocrinol Metab        ISSN: 2042-0188            Impact factor:   3.565


  78 in total

1.  Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month.

Authors:  G O'Driscoll; D Green; R R Taylor
Journal:  Circulation       Date:  1997-03-04       Impact factor: 29.690

2.  Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study.

Authors:  Thomas Tang; Julie Glanville; Catherine J Hayden; Davinia White; Julian H Barth; Adam H Balen
Journal:  Hum Reprod       Date:  2005-09-30       Impact factor: 6.918

3.  Differential activity of the cytochrome P450 17alpha-hydroxylase and steroidogenic acute regulatory protein gene promoters in normal and polycystic ovary syndrome theca cells.

Authors:  J K Wickenheisser; P G Quinn; V L Nelson; R S Legro; J F Strauss; J M McAllister
Journal:  J Clin Endocrinol Metab       Date:  2000-06       Impact factor: 5.958

4.  Treatment of hirsutism: comparisons between different antiandrogens with central and peripheral effects.

Authors:  F Fruzzetti; C Bersi; D Parrini; C Ricci; A R Genazzani
Journal:  Fertil Steril       Date:  1999-03       Impact factor: 7.329

5.  Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome.

Authors:  L J Moran; M Noakes; P M Clifton; L Tomlinson; C Galletly; R J Norman
Journal:  J Clin Endocrinol Metab       Date:  2003-02       Impact factor: 5.958

6.  Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin.

Authors:  Evanthia Diamanti-Kandarakis; Thomas Paterakis; Krystallenia Alexandraki; Christina Piperi; Athanasios Aessopos; Ilias Katsikis; Nikolaos Katsilambros; George Kreatsas; Dimitrios Panidis
Journal:  Hum Reprod       Date:  2006-02-23       Impact factor: 6.918

7.  Hirsutism: metabolic effects of two commonly used oral contraceptives and spironolactone.

Authors:  R A Wild; L M Demers; D Applebaum-Bowden; R Lenker
Journal:  Contraception       Date:  1991-08       Impact factor: 3.375

Review 8.  Morphology and morphogenesis of the Stein-Leventhal ovary and of so-called "hyperthecosis".

Authors:  P E Hughesdon
Journal:  Obstet Gynecol Surv       Date:  1982-02       Impact factor: 2.347

9.  A comparative study of the in vitro antioxidant activity of statins.

Authors:  Ferdinando Franzoni; Alfredo Quiñones-Galvan; Francesco Regoli; Ele Ferrannini; Fabio Galetta
Journal:  Int J Cardiol       Date:  2003-08       Impact factor: 4.164

10.  Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones.

Authors:  E Dahlgren; S Johansson; G Lindstedt; F Knutsson; A Odén; P O Janson; L A Mattson; N Crona; P A Lundberg
Journal:  Fertil Steril       Date:  1992-03       Impact factor: 7.329

View more
  2 in total

1.  Comparison of the effects of metformin, flutamide plus oral contraceptives, and simvastatin on the metabolic consequences of polycystic ovary syndrome.

Authors:  Ferdous Mehrabian; Hatav Ghasemi-Tehrani; Mahboobe Mohamadkhani; Maryam Moeinoddini; Pooya Karimzadeh
Journal:  J Res Med Sci       Date:  2016-02-23       Impact factor: 1.852

Review 2.  Role of Statin Drugs for Polycystic Ovary Syndrome.

Authors:  Lisa Cassidy-Vu; Edwina Joe; Julienne K Kirk
Journal:  J Family Reprod Health       Date:  2016-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.